Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.7.2.4: aspartate kinase

This is an abbreviated version!
For detailed information about aspartate kinase, go to the full flat file.

Word Map on EC 2.7.2.4

Reaction

ATP
+
L-aspartate
=
ADP
+
4-phospho-L-aspartate

Synonyms

AK, AK II, AK III, AK-HSDH, AK-HSDH I, AK-HSDH1, AK-HSDH2, AK-HseDH, AK-R7, AK-ts31d, AK1, AK2, AK3, AKbeta, AKII, AKIII, AKsyn, Ask, ASK1, ASK2, Ask_Ect, Ask_LysC, Asp kinase-homoserine dehydrogenase, aspartate kinase, aspartate kinase (phosphorylating), aspartate kinase 1, aspartate kinase 2, aspartate kinase 3, aspartate kinase beta, aspartate kinase I, aspartate kinase II, aspartate kinase III, aspartic kinase, aspartokinase, aspartokinase 1-homoserine dehydrogenase 1, aspartokinase 2, aspartokinase 3, aspartokinase I, aspartokinase II, aspartokinase III, aspartokinase-homoserine dehydrogenase, beta-aspartokinase, bifunctional aspartate kinase-homoserine dehydrogenase, BT, BTT, CgAK, dap-aspartokinase, HOM3 product, HOM3-R7 product, HOM3-ts31d product, HseDH, LT-aspartokinase, lysC, lysine-sensitive aspartokinase 3, More, MtbAKbeta, nspJ, Thr-sensitive aspartate kinase, thrA, thrA1, thrA2, TM_0547, XbAK

ECTree

     2 Transferases
         2.7 Transferring phosphorus-containing groups
             2.7.2 Phosphotransferases with a carboxy group as acceptor
                2.7.2.4 aspartate kinase

Engineering

Engineering on EC 2.7.2.4 - aspartate kinase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
I441A
-
site-directed mutagenesis
I552A
-
site-directed mutagenesis
Q443A
-
site-directed mutagenesis
Q524A
-
site-directed mutagenesis
S2207A
-
phenotype Thr- Met- Ura-
S2207A/pM1-1
-
mutant S2207A complemented with plasmid pM1-1, phenotype Thr+ Met+ Ura+
G10D/G324W
G345D
A279T
-
isolated from Corynebacterium glutamicum strain IWJ001, aspartate kinase mutant AKA279T is encoded by gene lysC1. The mutant enzymes is completely resistant to feed-back inhibition by L-threonine and L-lysine
D45A
-
the inhibition of CgAK by lysine is substantially reduced in D45A mutant
E114A
F115A
G110A
mutant enzyme shows normal and negligible response to Thr and Lys, dimerized by Thr
K106A
mutant showing change in Lys response
M105A
mutant showing change in Lys response
N50A
mutant showing change in Lys response
S301F
-
the S301F mutant exhibits resistance to feedback inhibition by lysine and threonine, showing activity in the presence of both lysine and threonine
T112A
V111A
V51A
mutant showing change in Lys response
A279T
-
isolated from Corynebacterium glutamicum strain IWJ001, aspartate kinase mutant AKA279T is encoded by gene lysC1. The mutant enzymes is completely resistant to feed-back inhibition by L-threonine and L-lysine
-
A380I
-
the mutant has 11.32fold higher enzyme activity than the wild type enzyme, enhanced thermal stability and shows weakened inhibition with L-lysine
M372I/T379W
-
the mutant shows 16.51fold higher activity, weakened inhibitory effect of L-lysine and significantly improved thermostability as compared to the wild type enzyme
R169A
site-directed mutagenesis, the Km for aspartate is decreased compared to the wild-type enzyme
R169D
site-directed mutagenesis, the mutant shows 2.57fold higher catalytic activity with aspartate than the wild-type enzyme
R169H
site-directed mutagenesis, the mutant shows 2.13fold higher catalytic activity with aspartate than the wild-type enzyme
R169P
site-directed mutagenesis, the mutant shows 2.25fold higher catalytic activity with aspartate than the wild-type enzyme
R169Y
site-directed mutagenesis, the mutant shows 4.7fold higher catalytic activity with aspartate than the wild-type enzyme. The three-dimensional structure of R169Y is more stable than that of the wild-type
T379 F
-
the mutant shows 2.65fold higher enzymatic activity compared to the wild type enzyme
T379E
-
the mutant shows 4.66fold higher enzymatic activity compared to the wild type enzyme
T379K
-
the mutant shows 5.25fold higher enzymatic activity compared to the wild type enzyme
T379L
-
the mutant shows 9.16fold higher enzymatic activity compared to the wild type enzyme
Y198N/D201M
-
the mutant shows 18.26fold increased activity compared to the wild type enzyme, is less inhibited by L-lysine and L-threonine and activated by Lys + Met, Thr + Met, Lys + Thr + Met at 5 and 10 mM concentration
M372I/T379W
-
the mutant shows 16.51fold higher activity, weakened inhibitory effect of L-lysine and significantly improved thermostability as compared to the wild type enzyme
-
DR1365
C428R
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
E346A
-
mutation reduces feedback-inhibition of AK1 by L-threonine without significant change in enzymatic activity
E346R
-
mutation within L-lysine binding site desensitizes AK3 from L-lysine inhibition. Mutant shows reduced L-lysine inhibition
F329R
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
G323D
-
mutation within L-lysine binding site desensitizes AK3 from L-lysine inhibition. Mutant shows reduced L-lysine inhibition
G433R
site-directed mutagenesis, strain HS33/pACYC-pycP458S-thrAG433R-lysC shows increased homoserine dehydrogenase activity (62.4% of the maximum theoretical yield)
H320A
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
I337P
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
I344P
-
mutation reduces feedback-inhibition of AK1 by L-threonine without significant change in enzymatic activity
I427P
-
mutation reduces feedback-inhibition of AK1 by L-threonine without significant change in enzymatic activity
L325F
-
mutation within L-lysine binding site desensitizes AK3 from L-lysine inhibition. Mutant shows reduced L-lysine inhibition
M251P
-
mutation destroys van der Waals interaction significantly which releases L-lysine inhibition
M318I
M417I
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
N424A
-
mutation reduces feedback-inhibition of AK1 by L-threonine without significant change in enzymatic activity
N426A
-
mutation reduces feedback-inhibition of AK1 by L-threonine without significant change in enzymatic activity
P458S
site-directed mutagenesis, strain HS33/pACYC-pycP458S-thrAG433R-lysC shows increased homoserine dehydrogenase activity (62.4% of the maximum theoretical yield)
Q351A
-
mutation reduces feedback-inhibition of AK1 by L-threonine without significant change in enzymatic activity
R305A
-
mutation destroys van der Waals interaction significantly which releases L-lysine inhibition
R416A
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
S315A
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
S338L
-
mutation within L-lysine binding site desensitizes AK3 from L-lysine inhibition. Mutant shows reduced L-lysine inhibition
S345L
-
mutation within L-lysine binding site desensitizes AK3 from L-lysine inhibition. Mutant shows reduced L-lysine inhibition
T253R
-
mutation leads to repulse interaction with Arg305 which destroys the allosteric regulation by L-lysine
T344M
T352I
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
V339A
-
mutation within L-lysine binding site desensitizes AK3 from L-lysine inhibition. Mutant shows reduced L-lysine inhibition
V347M
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
V349M
-
mutation is not directly involved in L-lysine binding. Mutation located within regulatory domain, participates in the allosteric regulation within regulatory domain. Mutation greatly reduces L-lysine inhibition
M318I
-
mutant enzyme T344M is more conducive to L-lysine production than mutant M318I
-
T344M
-
mutant enzyme T344M is more conducive to L-lysine production than mutant M318I
-
G433R
-
site-directed mutagenesis, strain HS33/pACYC-pycP458S-thrAG433R-lysC shows increased homoserine dehydrogenase activity (62.4% of the maximum theoretical yield)
-
S449L
transgenic plants expressing the mutant enzyme show a 6.6fold increased free lysine content
T448M
transgenic plants expressing the mutant enzyme show about 2fold increased free lysine content
D182/R184A
the mutations decrease the enzyme activities to about 65%
G152L
the mutant shows about 35% activity compared to the wild type enzyme
H399A
the mutant shows wild type activity
N371A/I372A
the mutations do not affect the ATP binding with threonine
R150A
the mutant shows about 30% activity compared to the wild type enzyme
S12C/S231C
the mutant shows wild type activity
S378A/E202A
V357/M351A
the mutant shows reduced activity compared to the wild type enzyme
A406T
-
site-directed mutagenesis, 30fold more strongly inhibited by threonine
D34E
wild type background
E254A
-
9.1fold decrease in kcat for aspartate and 11fold decrease in kcat for ATP
E279A
-
kcat is decreased 47 times for aspartate and 44 times for ATP
E282D
feedback-resistant
G25D
-
site-directed mutagenesis, reduced affinity for its substrates aspartate and ATP
H292A
-
4.5 times increase in Km for ATP and 120 times decrease in kcat for ATP
H292Q
-
no significant differences to wild type
H497A
-
kcat is decreased 6.7fold for both substrates
K18A
-
Km values for both substrates similar to wild type
K18Q
-
Km values for both substrates similar to wild type
K18R
-
Km values for aspartate similar to wildtype, Km value for ATP 2.9fold decreased
K26I
-
site-directed mutagenesis, reduced affinity for its substrates aspartate and ATP
R419A
-
10fold decrease in kcat for aspartate and 8.9fold decrease in kcat for ATP
S23A
-
differs significantly only in the kcat/Km ratio, which is decreased 4fold for aspartate and 3.7fold for ATP
S399F
feedback-resistant
T22A
-
Km for ATP increases 4.2fold
T295V
-
6.7 times decrease in the kcat/Km ratio for ATP
I119V/M68V/T309
random mutagenesis by error-prone PCR and subsequent site-directed mutagenesis, the mutations remove the regulation from the Ask wild type enzyme and conferre a feedback-inhibition resistance
I19V/M68V/T309A
removes regulation from the Ask wild type enzyme and conferrs a feedback-inhibition resistance, assay mixture with 100 mM L-lysine plus 100 mM L-threonine reveals more than 80% activity
I119V/M68V/T309
-
random mutagenesis by error-prone PCR and subsequent site-directed mutagenesis, the mutations remove the regulation from the Ask wild type enzyme and conferre a feedback-inhibition resistance
-
I19V/M68V/T309A
-
removes regulation from the Ask wild type enzyme and conferrs a feedback-inhibition resistance, assay mixture with 100 mM L-lysine plus 100 mM L-threonine reveals more than 80% activity
-
A157L
-
site-directed mutagenesis
A189L
-
site-directed mutagenesis
A23L
-
site-directed mutagenesis
A42S
-
site-directed mutagenesis
D154A
-
site-directed mutagenesis
D154N
-
site-directed mutagenesis
D174A
-
site-directed mutagenesis
D182A
-
site-directed mutagenesis
E202A
-
site-directed mutagenesis
F136A
-
site-directed mutagenesis
G10A
-
site-directed mutagenesis
G10D/G324W
construction of an engineered chimeric mutant enzyme containing the N-terminal catalytic region from Bacillus subtilis AKII and the C-terminal region from Thermus thermophilus AKII, through random mutagenesis and then screened using a high throughput synthetic RNA device which comprises of an L-lysine-sensing riboswitch and a selection module. Of three evolved aspartate kinases, the best mutant BT3 shows 160% increased in vitro activity compared to the wild-type enzyme from Bacillus subtilis. The mutant enzymes is feedback-resistant to L-lysine
G135A
-
site-directed mutagenesis
G149A
-
site-directed mutagenesis
G152A
-
site-directed mutagenesis
G177A
-
site-directed mutagenesis
G73A
-
site-directed mutagenesis
I171A
-
site-directed mutagenesis
L148A
-
site-directed mutagenesis
P183A
-
site-directed mutagenesis
R150A
-
site-directed mutagenesis
S12A
-
site-directed mutagenesis
S153A
-
site-directed mutagenesis
S41A
-
site-directed mutagenesis
T238A
-
site-directed mutagenesis
T47A
-
site-directed mutagenesis
V39A
-
site-directed mutagenesis
Y8A
-
site-directed mutagenesis
E257K
-
mutation of the conserved Glu-257 to Lys or the double mutations T359I/E257K render the enzyme insensitive to L-lysine with 86- and 112fold increases in IC50 values, respectively, when compared to the wild-type enzyme. E257K and E257K/T359I alleles exhibit a 1.2- to 1.7fold decrease in Vmax value and 2- to 6fold decrease in kcat/Km value for either substrate compared to wild-type
T359I
-
mutation increases the L-lysine IC50 value by 104fold, but no substantial differences are observed in kinetic parameters except lower Km ATP value compared to the wild-type enzyme. Seed-specific expression of the feedback-resistant mutant T359I or mutant E257K results in increases of free L-threonine levels of up to 100fold in R1 soybean seed when compared to wild-type
T359I/E257K
-
mutation of the conserved Glu-257 to Lys or the double mutations T359I/E257K render the enzyme insensitive to L-lysine with 86- and 112fold increases in IC50 values, respectively, when compared to the wild-type enzyme. E257K and E257K/T359I alleles exhibit a 1.2- to 1.7fold decrease in Vmax value and 2- to 6fold decrease in kcat/Km value for either substrate compared to wild-type
additional information